Amplifying effect of endothelin-1 on serotonin-induced vasoconstriction of human umbilical artery. 1995

Y Okatani, and K Taniguchi, and Y Sagara
Department of Obstetrics and Gynecology, Kochi Medical School, Japan.

OBJECTIVE The purpose of this study was to evaluate the role of endothelin-1 in serotonin-induced vasoconstriction in human umbilical artery. METHODS Umbilical arteries collected from 41 normal subjects at term were cut helically and suspended in an organ bath for recording isometric mechanical activity. In study 1 we measured the concentration-contraction response to serotonin or endothelin-1 according to a cumulative concentration schedule. In study 2 vessels were preincubated with a subthreshold concentration of endothelin-1 (100, 250, or 500 pg/ml), and then serotonin was added cumulatively. In study 3 vessels were preincubated with H-7 (3 x 10(-6) mol/L), an inhibitor of protein kinase C, or with 12-tetradecanoylphorbol-13 acetate (10(-9) to 10(-7) mol/L), an activator of protein kinase C; then serotonin was added cumulatively. In study 4 vessels were suspended in a calcium-free solution containing 2 mmol/L ethylene glycol-bis(beta-aminoethyl ether) N,N,N',N'-tetraacetic acid and 60 mmol/L potassium chloride, and then a cumulative concentration-response curve to calcium chloride (10(-7) to 10(-3) mol/L) was constructed for vessels pretreated with endothelin-1, 500 pg/ml or 5 ng/ml. RESULTS The threshold concentrations of serotonin and endothelin-1 were 5 and 1 ng/ml, respectively. A subthreshold concentration of endothelin-1 (250 or 500 pg/ml) potentiated significantly the concentration response to serotonin (p < 0.084, p < 0.009, by analysis of variance). Pretreatment with H-7 significantly suppressed the amplifying effect of endothelin-1 on serotonin-induced contraction. Treatment with 12-tetradecanoylphorbol-13 acetate (10(-7) or 10(-8) mol/L) significantly potentiated the contractile response to serotonin (p < 0.0003, p < 0.015). The sensitivity of the arterial segments to calcium chloride in the presence of a subthreshold concentration of endothelin-1 did not differ from that in the control group. CONCLUSIONS Endothelin-1 at a subthreshold concentration amplified the smooth muscle contraction induced by serotonin. The mechanism of action may be mediated by activation of intracellular protein kinase C.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D002122 Calcium Chloride A salt used to replenish calcium levels, as an acid-producing diuretic, and as an antidote for magnesium poisoning. Calcium Chloride Dihydrate,Calcium Chloride, Anhydrous
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations

Related Publications

Y Okatani, and K Taniguchi, and Y Sagara
October 2001, Journal of pineal research,
Y Okatani, and K Taniguchi, and Y Sagara
April 2000, Biochemical and biophysical research communications,
Y Okatani, and K Taniguchi, and Y Sagara
August 2019, Life sciences,
Y Okatani, and K Taniguchi, and Y Sagara
October 2000, Biochemical and biophysical research communications,
Y Okatani, and K Taniguchi, and Y Sagara
October 1996, Acta obstetricia et gynecologica Scandinavica,
Y Okatani, and K Taniguchi, and Y Sagara
February 1996, Acta obstetricia et gynecologica Scandinavica,
Y Okatani, and K Taniguchi, and Y Sagara
July 1991, Circulation research,
Y Okatani, and K Taniguchi, and Y Sagara
January 1998, Journal of cardiovascular pharmacology,
Y Okatani, and K Taniguchi, and Y Sagara
April 1996, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
Y Okatani, and K Taniguchi, and Y Sagara
December 1996, Human reproduction (Oxford, England),
Copied contents to your clipboard!